3.4. Subgroup Analyses
arterial stiffness, diabetes
REGRESSION, ARTERIAL STIFFNESS, DIABETES
The pre-specified subgroup analyses are illustrated in In patients without DM, there was no significant differences in the absolute cfPWV change and percent cfPWV change in both groups at 12 weeks and 24 weeks. Both oral MK-7 treatment and control groups exhibited similar progression of cfPWV (treatment 34.5% vs. control 28.1%, In the subgroup, there were no significant differences in the percent change of cPWV and cPWV progression in both baseline serum Ca > 10 mg/dL and serum Ca ≤ 10 mg/dL (HD frequency was also explored by subgroup analysis, patients who received oral MK-7 treatment group have a less percent change in cPWV at 24 weeks compared with the control group in the thrice-a-week HD subgroup [−5.8 (−19.6, 2.3)% vs. −10.0 (−21.7, 2.8)%, Post-hoc analysis using univariate and multivariable logistic regression that included intervention, age, diabetes status, SBP, HD frequency, dialysate Ca concentration, and smoking status did not find any independent predictors of the progression of arterial stiffness (